Antifungal drug improves key cystic fibrosis biomarkers in clinical study
A drug widely used to treat fungal infections improved key biomarkers in lung tissue cultures as well as in the noses of patients with cystic fibrosis, a clinical study found.
Read Original Article: Antifungal drug improves key cystic fibrosis biomarkers in clinical study »
